Helicobacter Pylori and Athlete Health
DOI:
https://doi.org/10.5281/zenodo.14591992Keywords:
Athlete, Digestive System, Health, Helicobacter Pylori, Performance.Abstract
Helicobacter pylori (H. pylori) is an important infectious agent that can cause various digestive system problems such as gastritis, peptic ulcers, and, in advanced stages, stomach cancer. This review aims to emphasize the importance of H. pylori infection on athletes' health and current information about the microorganism by examining the importance of H. pylori on athlete performance. H. pylori is one of the most common pathogens in the world. One of this bacterium's most common disease manifestations is gastritis, a serious public health problem. Today, gastritis is one of the most common digestive system disorders. It can directly affect athletes' health and performance, especially those closely related to nutrition and digestion. If left untreated, H. pylori-induced gastritis can progress to ulcer formation and lead to more serious and chronic digestive problems. This chronic process can seriously affect athletes' nutrition, performance, and sleep patterns, all of which are critically important for optimal athlete performance. For all these reasons, this review aims to compile the current knowledge on H. pylori and its effects on athlete health and performance and to present the latest developments in diagnosis and treatment.
References
Achtman M. Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu Rev Microbiol. 2008; 62:53-70.
Ardalani H, Hadipanah A, Sahebkar A. Medicinal Plants in the Treatment of Peptic Ulcer Disease: A Review. Mini Rev Med Chem. 2020; 20(8): 662-702.
Bhattacharjee A, Sahoo OS, Sarkar A, Bhattacharya S, Chowdhury R, Kar S, et al. Infiltration to infection: key virulence players of Helicobacter pylori pathogenicity. Infection. 2024; 52(2): 345-384.
Brown H, Cantrell S, Tang H, Epplein M, Garman KS. Racial Differences in Helicobacter pylori Prevalence in the US: A Systematic Review. Gastro Hep Adv. 2022;1(5):857-868.
Burucoa C, Axon A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017; 22 Suppl 1.
Çelik MM, Duran N. An experimental in-vitro study to evaluate the anti-helicobacter activity of Glycyrrhetinic acid}, Revista Romana de Medicina de Laborator, 2019; 27: 63-71.
Chmiela M, Kupcinskas J. Review: Pathogenesis of Helicobacter pylori infection. Helicobacter. 2019; 24 Suppl 1(Suppl Suppl 1):e12638.
Choe YH, Kwon YS, Jung MK, Kang SK, Hwang TS, Hong YC. Helicobacter pylori-associated iron-deficiency anemia in adolescent female athletes. J Pediatr. 2001; 139(1): 100-4.
Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014; 19 Suppl 1:1-5.
Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000; 181(4): 1359-63.
FitzGerald R, Smith SM. An Overview of Helicobacter pylori Infection. Methods Mol Biol. 2021; 2283: 1-14.
Goderska K, Agudo Pena S, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 2018 Jan;102(1):1-7.
Haarhuis JE, Kardinaal A, Kortman GAM. Probiotics, prebiotics and postbiotics for better sleep quality: a narrative review. Benef Microbes. 2022; 13(3): 169-182.
Kalali B, Mejías-Luque R, Javaheri A, Gerhard M. H. pylori virulence factors: influence on immune system and pathology. Mediators Inflamm. 2014; 2014: 426309.
Lee HA, Kim JY, Kim J, Nam B, Kim O. Anti-Helicobacter pylori activity of acomplex mixture of Lactobacillus paracasei HP7 including the extract of Perilla frutescens var. acuta and Glycyrrhiza glabra. Lab Anim Res. 2020; 36:40.
Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016; 150(5): 1113-1124.e5.
Leja M, Grinberga-Derica I, Bilgilier C, Steininger C. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019; 24 Suppl 1: e12635.
Liang B, Yuan Y, Peng XJ, Liu XL, Hu XK, Xing DM. Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics. Front Cell Infect Microbiol. 2022; 12: 1042070.
Maixner F, Krause-Kyora B, Turaev D, Herbig A, Hoopmann MR, Hallows JL, et al. The 5300-year-old Helicobacter pylori genome of the Iceman. Science. 2016; 351(6269): 162-165.
Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984; 1(8390): 1311-5.
Muzaheed. Helicobacter pylori Oncogenicity: Mechanism, Prevention, and Risk Factors. ScientificWorldJournal. 2020; 2020: 3018326.
Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases. 2021; 9(4): 66.
Rahnama M, Mehrabani D, Japoni S, Edjtehadi M, Saberi Firoozi M. The healing effect of licorice (Glycyrrhiza glabra) on Helicobacter pylori infected peptic ulcers. J Res Med Sci. 2013; 18(6): 532-3.
Reyes VE. Helicobacter pylori and Its Role in Gastric Cancer. Microorganisms. 2023; 11(5): 1312.
Sahle Z. Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis. Infection and Drug Resistance, 2022; 15: 21-34.
Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020; 39(4): 1179-1203.
Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol. 2022; 53(1): 33-50.
Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis. 2013; 14(7): 341-9.
Silva DG, Stevens RH, Macedo JM, Albano RM, Falabella ME, Fischer RG. Presence of Helicobacter pylori in supragingival dental plaque of individuals with periodontal disease and upper gastric diseases. Arch Oral Biol. 2010; 55: 896-901.
Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastroenterol. 2019; 25(33): 4870-4884.
Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002; 347(15): 1175-86.
Suzuki H, Iwasaki E, Hibi T. Helicobacter pylori and gastric cancer. Gastric Cancer. 2009; 12(2): 79-87.
Tek E. Glycyrrhetinic asit, streptococcus thermophilus ve lactobacillus casei'nin helicobacter pylori'ye karşı in-vitro, in-vivo etkinliği ve moleküler mekanizmalar, Hatay Mustafa Kemal University, Sağlık Bilimleri Enstitüsü, Doktora Tezi, 2022.
Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014 Apr 10;345(2):196-202.
Wang YC. Medicinal plant activity on Helicobacter pylori related diseases. World J Gastroenterol. 2014; 20(30): 10368-82.
Yamaoka Y. Revolution of Helicobacter pylori treatment. J Gastroenterol Hepatol. 2024; 39(6): 1016-1026.
Zolkiewicz J, Marzec A, Ruszczyński M, Feleszko W. Postbiotics-A Step Beyond Pre- and Probiotics. Nutrients. 2020; 12(8): 2189.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 IJPANH
This work is licensed under a Creative Commons Attribution 4.0 International License.
